| pubmed-article:19009924 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19009924 | lifeskim:mentions | umls-concept:C0033011 | lld:lifeskim |
| pubmed-article:19009924 | lifeskim:mentions | umls-concept:C0220908 | lld:lifeskim |
| pubmed-article:19009924 | lifeskim:mentions | umls-concept:C0040557 | lld:lifeskim |
| pubmed-article:19009924 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:19009924 | lifeskim:mentions | umls-concept:C2728259 | lld:lifeskim |
| pubmed-article:19009924 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19009924 | pubmed:dateCreated | 2008-11-17 | lld:pubmed |
| pubmed-article:19009924 | pubmed:abstractText | (1) To evaluate the efficacy of the Toxoplasma gondii screening program among Nunavik pregnant women in identifying seroconversions during pregnancy and performing an appropriate follow-up of the seroconverted women and their child; and (2) to evaluate the consequences of congenital Toxoplasma gondii infection. | lld:pubmed |
| pubmed-article:19009924 | pubmed:language | fre | lld:pubmed |
| pubmed-article:19009924 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19009924 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19009924 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19009924 | pubmed:issn | 0008-4263 | lld:pubmed |
| pubmed-article:19009924 | pubmed:author | pubmed-author:GingrasSuzann... | lld:pubmed |
| pubmed-article:19009924 | pubmed:author | pubmed-author:ProulxJean-Fr... | lld:pubmed |
| pubmed-article:19009924 | pubmed:author | pubmed-author:LibmanMichael... | lld:pubmed |
| pubmed-article:19009924 | pubmed:author | pubmed-author:HubertBrunoB | lld:pubmed |
| pubmed-article:19009924 | pubmed:author | pubmed-author:GrantJennifer... | lld:pubmed |
| pubmed-article:19009924 | pubmed:author | pubmed-author:LévesqueBenoi... | lld:pubmed |
| pubmed-article:19009924 | pubmed:author | pubmed-author:LavoieElaineE | lld:pubmed |
| pubmed-article:19009924 | pubmed:author | pubmed-author:NdassebeAngél... | lld:pubmed |
| pubmed-article:19009924 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19009924 | pubmed:volume | 99 | lld:pubmed |
| pubmed-article:19009924 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19009924 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19009924 | pubmed:pagination | 397-400 | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:meshHeading | pubmed-meshheading:19009924... | lld:pubmed |
| pubmed-article:19009924 | pubmed:articleTitle | [Evaluation of the efficacy of the Toxoplasma gondii screening program among pregnant women in Nunavik, 1994-2003]. | lld:pubmed |
| pubmed-article:19009924 | pubmed:affiliation | Unité de recherche en santé publique, Centre de Recherche du CHUL, Québec. | lld:pubmed |
| pubmed-article:19009924 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19009924 | pubmed:publicationType | English Abstract | lld:pubmed |
